IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nymox Pharmaceutical Corp

CUSIP: 67076P952 | 3 institutional holders

Quarters

Q3 2015Q2 2015Q1 2015Q4 2014Q3 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile